Oral Semaglutide and Cardiovascular Outcomes. Reply
- PMID: 40802953
- DOI: 10.1056/NEJMc2508958
Oral Semaglutide and Cardiovascular Outcomes. Reply
Comment on
-
Oral Semaglutide and Cardiovascular Outcomes in High-Risk Type 2 Diabetes.N Engl J Med. 2025 May 29;392(20):2001-2012. doi: 10.1056/NEJMoa2501006. Epub 2025 Mar 29. N Engl J Med. 2025. PMID: 40162642 Clinical Trial.
Publication types
LinkOut - more resources
Full Text Sources